Myelin-oligodendrocyte glycoprotein antibody-associated disease / 中华神经科杂志
Chinese Journal of Neurology
; (12): 643-649, 2022.
Article
en Zh
| WPRIM
| ID: wpr-933834
Biblioteca responsable:
WPRO
ABSTRACT
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently-established autoimmune central nervous system demyelinating disease, characterized by the detection of serum anti-myelin-oligodendrocyte glycoprotein antibody of IgG1 type. Sharing similar clinical manifestations with multiple sclerosis and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder, it has yet demonstrated a unique disease course, pathological and radiological features. Therefore, MOGAD should be regarded as a disease entity to carry out further investigation. This review intends to summarize its pathogenesis, diagnosis and treatment progresses, so as to provide guidance for clinical practice.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Guideline
Idioma:
Zh
Revista:
Chinese Journal of Neurology
Año:
2022
Tipo del documento:
Article